Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) EBIT (2020 - 2025)

Privia Health has reported EBIT over the past 6 years, most recently at $11.3 million for Q4 2025.

  • Quarterly results put EBIT at $11.3 million for Q4 2025, up 114.9% from a year ago — trailing twelve months through Dec 2025 was $34.2 million (up 101.6% YoY), and the annual figure for FY2025 was $34.2 million, up 101.6%.
  • EBIT for Q4 2025 was $11.3 million at Privia Health, down from $14.4 million in the prior quarter.
  • Over the last five years, EBIT for PRVA hit a ceiling of $14.4 million in Q3 2025 and a floor of -$193.2 million in Q2 2021.
  • Median EBIT over the past 5 years was $4.2 million (2024), compared with a mean of -$8.2 million.
  • Biggest five-year swings in EBIT: tumbled 3226.51% in 2021 and later soared 534.02% in 2025.
  • Privia Health's EBIT stood at -$19.3 million in 2021, then soared by 111.62% to $2.2 million in 2022, then crashed by 36.86% to $1.4 million in 2023, then soared by 269.58% to $5.2 million in 2024, then surged by 114.9% to $11.3 million in 2025.
  • The last three reported values for EBIT were $11.3 million (Q4 2025), $14.4 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.